Skip to main content
Addgene

pSIN4-CMV-K2M Citations (16)

Originally described in: Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA Science. 2009 Mar 26. PubMed Journal

Articles Citing pSIN4-CMV-K2M

Articles
Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, Rinn JL. Nat Genet. 2010 Dec;42(12):1113-7. Epub 2010 Nov 7. PubMed

Associated Plasmids
Derivation of induced pluripotent stem cells by lentiviral transduction. Nethercott HE, Brick DJ, Schwartz PH. Methods Mol Biol. 2011;767:67-85. doi: 10.1007/978-1-61779-201-4_6. PubMed
Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Kuo TC, Chen CT, Baron D, Onder TT, Loewer S, Almeida S, Weismann CM, Xu P, Houghton JM, Gao FB, Daley GQ, Doxsey S. Nat Cell Biol. 2011 Sep 11;13(10):1214-23. doi: 10.1038/ncb2332. PubMed
Chromatin-modifying enzymes as modulators of reprogramming. Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, Lander ES, Armstrong SA, Daley GQ. Nature. 2012 Mar 4;483(7391):598-602. doi: 10.1038/nature10953. PubMed

Associated Plasmids
Generation and characterization of leukemia inhibitory factor-dependent equine induced pluripotent stem cells from adult dermal fibroblasts. Whitworth DJ, Ovchinnikov DA, Sun J, Fortuna PR, Wolvetang EJ. Stem Cells Dev. 2014 Jul 1;23(13):1515-23. doi: 10.1089/scd.2013.0461. Epub 2014 Apr 1. PubMed
KLF4 N-terminal variance modulates induced reprogramming to pluripotency. Kim SI, Oceguera-Yanez F, Hirohata R, Linker S, Okita K, Yamada Y, Yamamoto T, Yamanaka S, Woltjen K. Stem Cell Reports. 2015 Apr 14;4(4):727-43. doi: 10.1016/j.stemcr.2015.02.004. Epub 2015 Mar 12. PubMed

Associated Plasmids
Two Histone Variants TH2A and TH2B Enhance Human Induced Pluripotent Stem Cell Generation. Huynh LM, Shinagawa T, Ishii S. Stem Cells Dev. 2016 Feb 1;25(3):251-8. doi: 10.1089/scd.2015.0264. Epub 2016 Jan 7. PubMed
Single-cell multimodal profiling reveals cellular epigenetic heterogeneity. Cheow LF, Courtois ET, Tan Y, Viswanathan R, Xing Q, Tan RZ, Tan DS, Robson P, Loh YH, Quake SR, Burkholder WF. Nat Methods. 2016 Oct;13(10):833-6. doi: 10.1038/nmeth.3961. Epub 2016 Aug 15. PubMed
Lentiviral Reprogramming of A-T Patient Fibroblasts to Induced Pluripotent Stem Cells. Nayler S, Kozlov SV, Lavin MF, Wolvetang E. Methods Mol Biol. 2017;1599:401-418. doi: 10.1007/978-1-4939-6955-5_29. PubMed
Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations. Lee JH, Salci KR, Reid JC, Orlando L, Tanasijevic B, Shapovalova Z, Bhatia M. Stem Cells. 2017 Sep;35(9):2095-2102. doi: 10.1002/stem.2655. Epub 2017 Jul 31. PubMed
A Human Gonadal Cell Model From Induced Pluripotent Stem Cells. Rodriguez Gutierrez D, Eid W, Biason-Lauber A. Front Genet. 2018 Oct 24;9:498. doi: 10.3389/fgene.2018.00498. eCollection 2018. PubMed
Platypus Induced Pluripotent Stem Cells: The Unique Pluripotency Signature of a Monotreme. Whitworth DJ, Limnios IJ, Gauthier ME, Weeratunga P, Ovchinnikov DA, Baillie G, Grimmond SM, Graves JAM, Wolvetang EJ. Stem Cells Dev. 2019 Feb 1;28(3):151-164. doi: 10.1089/scd.2018.0179. Epub 2019 Jan 9. PubMed
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming. Ebrahimi A, Sevinc K, Gurhan Sevinc G, Cribbs AP, Philpott M, Uyulur F, Morova T, Dunford JE, Goklemez S, Ari S, Oppermann U, Onder TT. Nat Chem Biol. 2019 May;15(5):519-528. doi: 10.1038/s41589-019-0264-z. Epub 2019 Apr 8. PubMed
Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Nakanishi M, Mitchell RR, Benoit YD, Orlando L, Reid JC, Shimada K, Davidson KC, Shapovalova Z, Collins TJ, Nagy A, Bhatia M. Cell. 2019 May 2;177(4):910-924.e22. doi: 10.1016/j.cell.2019.03.013. Epub 2019 Apr 11. PubMed
Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells. Guney-Esken G, Erol OD, Pervin B, Gurhan Sevinc G, Onder T, Bilgic E, Korkusuz P, Gunel-Ozcan A, Uckan-Cetinkaya D, Aerts-Kaya F. Stem Cell Res Ther. 2021 May 13;12(1):287. doi: 10.1186/s13287-021-02364-z. PubMed
AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation. Ugurlu-Cimen D, Odluyurt D, Sevinc K, Ozkan-Kucuk NE, Ozcimen B, Demirtas D, Enustun E, Aztekin C, Philpott M, Oppermann U, Ozlu N, Onder TT. Epigenetics Chromatin. 2021 Jul 2;14(1):32. doi: 10.1186/s13072-021-00406-7. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.